Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

The US EPA reference dose for methylmercury: sources of uncertainty.

Rice DC.

Environ Res. 2004 Jul;95(3):406-13.

PMID:
15220074
2.

Determination of a site-specific reference dose for methylmercury for fish-eating populations.

Shipp AM, Gentry PR, Lawrence G, Van Landingham C, Covington T, Clewell HJ, Gribben K, Crump K.

Toxicol Ind Health. 2000 Nov;16(9-10):335-438. Review.

PMID:
11762928
3.

Uncertainties in the reference dose for methylmercury.

Dourson ML, Wullenweber AE, Poirier KA.

Neurotoxicology. 2001 Oct;22(5):677-89. Review.

PMID:
11770889
5.

Derivation of a bisphenol A oral reference dose (RfD) and drinking-water equivalent concentration.

Willhite CC, Ball GL, McLellan CJ.

J Toxicol Environ Health B Crit Rev. 2008 Feb;11(2):69-146. doi: 10.1080/10937400701724303. Review.

PMID:
18188738
6.

Contending with contradictory data in a risk assessment context: the case of methylmercury.

Jacobson JL.

Neurotoxicology. 2001 Oct;22(5):667-75. Review.

PMID:
11770888
7.

Toxicology and human health assessment of decabromodiphenyl ether.

Hardy ML, Banasik M, Stedeford T.

Crit Rev Toxicol. 2009 Nov;39 Suppl 3:1-44. doi: 10.1080/10408440902837967. Review.

PMID:
19874087
8.

Derivation of U.S. EPA's oral Reference Dose (RfD) for methylmercury.

Rice G, Swartout J, Mahaffey K, Schoeny R.

Drug Chem Toxicol. 2000 Feb;23(1):41-54. Review.

PMID:
10711388
9.

Methylmercury: significance of intrauterine and postnatal exposures.

Grandjean P, Weihe P, Nielsen JB.

Clin Chem. 1994 Jul;40(7 Pt 2):1395-400. Review.

10.

A procedure for developing risk-based reference doses.

Gaylor DW, Kodell RL.

Regul Toxicol Pharmacol. 2002 Apr;35(2 Pt 1):137-41. Review.

PMID:
12051999
11.

Methylmercury: a new look at the risks.

Mahaffey KR.

Public Health Rep. 1999 Sep-Oct;114(5):396-9, 402-13. Review.

12.

Application of a physiologically based pharmacokinetic model for isopropanol in the derivation of a reference dose and reference concentration.

Gentry PR, Covington TR, Andersen ME, Clewell HJ 3rd.

Regul Toxicol Pharmacol. 2002 Aug;36(1):51-68. Review.

PMID:
12383718
13.

Comparison of four human studies of perinatal exposure to methylmercury for use in risk assessment.

Cicmanec JL.

Toxicology. 1996 Jul 17;111(1-3):157-62. Review. Erratum in: Toxicology 1997 May 16;119(3):239.

PMID:
8711732
14.

The benchmark dose method--review of available models, and recommendations for application in health risk assessment.

Filipsson AF, Sand S, Nilsson J, Victorin K.

Crit Rev Toxicol. 2003;33(5):505-42. Review.

PMID:
14594105
15.

Human variability in mercury toxicokinetics and steady state biomarker ratios.

Bartell SM, Ponce RA, Sanga RN, Faustman EM.

Environ Res. 2000 Oct;84(2):127-32. Review.

PMID:
11068925
16.

Mercury exposure and child development outcomes.

Davidson PW, Myers GJ, Weiss B.

Pediatrics. 2004 Apr;113(4 Suppl):1023-9. Review.

PMID:
15060195
17.

Good fish/bad fish: a composite benefit-risk by dose curve.

Gochfeld M, Burger J.

Neurotoxicology. 2005 Aug;26(4):511-20. Review.

PMID:
15979722
18.
19.

Biomonitoring Equivalents for triclosan.

Krishnan K, Gagné M, Nong A, Aylward LL, Hays SM.

Regul Toxicol Pharmacol. 2010 Oct;58(1):10-7. doi: 10.1016/j.yrtph.2010.06.004. Review.

PMID:
20541577
20.

Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects.

Shipp A, Lawrence G, Gentry R, McDonald T, Bartow H, Bounds J, Macdonald N, Clewell H, Allen B, Van Landingham C.

Crit Rev Toxicol. 2006 Jul-Aug;36(6-7):481-608. Review.

PMID:
16973444

Supplemental Content

Support Center